CELLDEX THERAPEUTICS INC (CLDX)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for CLDX
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| CLDX | Director | 73 | ["Former Audit partner for numerous public companies","Life Sciences Industry Leader for the New York Metro Area until 2009","B.S. in Accounting from Lehigh University","Certified Public Accountant"] | ["Audit"] | 2026 |
Biography sourced from the proxy statement filing.
KEITH L. BROWNLIE, 73
CARIEER HIGHLIGHTS
Director since June 2017
Ernst & Young LLP
Former Audit partner for numerous public companies and was the Life Sciences Industry Leader for the New York Metro Area until 2009
PUBLIC BOARDS: 1
Soligenix, Inc.
Board of directors from 2010 until 2019
COMMITTEES: Audit
Phio Pharmaceuticals Corp. (formerly RXi Pharmaceuticals Corporation)
Board of directors from 2012 until 2019
EDUCATION: B.S. in Accounting from Lehigh University and is a Certified Public Accountant
Cancer Genetics, Inc.
Board of directors from 2013 to 2014
EpiCept Corporation
Board of directors from 2011 to 2013